Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.09B 899M 790M 734M 675M 1.27B 87.04B 1.29B 8.78B 3.43B 42.45B 3.37B 3.3B 147B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 6.96B 1.03B 904M 840M 772M 1.45B 99.54B 1.47B 10.04B 3.92B 48.55B 3.86B 3.78B 168B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 day+1.13%
1 week-5.11%
Current month+2.76%
1 month-4.90%
3 months-10.44%
6 months+4.45%
Current year+2.53%
1 week 4.37
Extreme 4.37
4.58
1 month 4.26
Extreme 4.26
4.83
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.94
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.83
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-01
Director of Finance/CFO 41 2020-12-28
Corporate Officer/Principal 42 2014-01-26
Director TitleAgeSince
Director/Board Member 58 2007-12-24
Chairman 56 2026-03-26
Director/Board Member 42 2014-01-26
Date Insider Type Main position Quantity % Market Cap.
9/21/20 Sell

Chairman

1,940,600 0.2495%
9/18/20 Sell

Chairman

296,500 0.0381%
9/18/20 Sell

Director

3,670,000 0.4719%
Change 5-day change 1-year change 3-year change Capi.($)
+1.13%-5.11%-16.17%-45.61% 899M
-0.10%-0.79%-8.54%-3.35% 13.62B
-0.65%-4.12%-28.73%-50.29% 5.23B
-0.31%-0.23%+0.57%-1.00% 4.83B
-1.74%-2.53%+7.97%-30.00% 4.18B
-0.45%-3.65%+3.42%-7.77% 3.71B
-1.64%+2.93%-2.10%-1.75% 3.68B
-0.31%+0.13%-1.42%+12.88% 3.52B
-1.25%-2.29%-11.58%-21.43% 2.46B
+0.85%-1.91%-3.29%+49.54% 1.88B
Average -0.45%+1.19%-5.99%-9.88% 4.4B
Weighted average by Cap. -0.52%+1.14%-6.36%-9.75%

Financials

2024 2025
Net sales 3.83B 565M 497M 461M 424M 796M 54.69B 810M 5.52B 2.15B 26.68B 2.12B 2.07B 92.55B 3.05B 450M 396M 368M 338M 634M 43.59B 646M 4.4B 1.72B 21.26B 1.69B 1.65B 73.75B
Net income 33.62M 4.96M 4.37M 4.06M 3.73M 6.99M 481M 7.12M 48.5M 18.92M 234M 18.63M 18.23M 813M -104M -15.41M -13.55M -12.59M -11.58M -21.71M -1.49B -22.1M -151M -58.72M -728M -57.84M -56.59M -2.52B
Net Debt 1.4B 207M 182M 169M 155M 291M 20.02B 297M 2.02B 788M 9.76B 776M 759M 33.88B 875M 129M 114M 106M 97.03M 182M 12.5B 185M 1.26B 492M 6.1B 485M 474M 21.16B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
26-07-23 CN¥4.460 +1.13% 5,085,600
26-07-22 CN¥4.410 -0.68% 5,073,400
26-07-21 CN¥4.440 -1.33% 8,410,516
26-07-20 CN¥4.500 0.00% 7,895,900
26-07-17 CN¥4.500 -4.26% 11,552,400

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock